首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Hemostatic factors in hypertriglyceridemic men: effects of a fatty meal before and after triglyceride-lowering treatment with etofibrate.
【24h】

Hemostatic factors in hypertriglyceridemic men: effects of a fatty meal before and after triglyceride-lowering treatment with etofibrate.

机译:高甘油三酯血症男性的止血因素:依托贝特降低甘油三酸酯治疗前后的脂肪餐的影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aims of this double-blind study were to examine whether in hypertriglyceridemic men the ingestion of a standardized fatty meal alters hemostasis negatively and whether triglyceride-lowering treatment with etofibrate for 6 weeks alters fasting and postprandial hemostasis positively, thus reversing the potential negative effects of a fatty meal on postprandial hemostasis. To answer these questions, we measured markers of hemostasis immediately before a standardized fatty meal, and 4, 6, 8, and 10 hours after the meal in 21 hypertriglyceridemic men both before and after treatment with etofibrate. We found that the concentration of plasmin alpha2antiplasmin complex markedly increased for at least 10 hours after the fatty meal, but that the activation of factor XII and the concentration of prothrombin activation fragment1+2 decreased after the fatty meal. These results on factor XII contradict reported in vitro data. Triglyceride-lowering treatment with etofibrate in 10 of these men for 6 weeks increased fasting and postprandial protein C and plasminogen and also slightly decreased the activation of fXII; however, it did not reverse the postprandial increase of PAP or change the decrease of prothrombin activation fragment1+2. Our findings indicate that postprandial lipoproteins alter markers of hemostasis positively in an antithrombotic and profibrinolytic direction. In addition, triglyceride-lowering treatment with etofibrate only slightly improves markers of fasting and postprandial hemostasis in an antithrombotic and profibrinolytic direction.
机译:这项双盲研究的目的是检查高甘油三酯血症男性摄入标准脂肪餐是否对止血有负面影响,依托非贝特降低甘油三酯治疗6周是否对空腹和餐后止血有正面影响,从而逆转潜在的负面影响餐后止血的脂肪餐。为了回答这些问题,我们在21名高甘油三酸酯血症的男性患者中,在依托非贝特治疗之前和之后,在标准化脂肪餐之前以及餐后4、6、8和10小时测量了止血指标。我们发现脂肪餐后至少10小时内纤溶酶α2抗纤溶酶复合物的浓度显着增加,但是脂肪餐后纤溶酶XII的活化和凝血酶原活化片段1 + 2的浓度降低。这些关于XII因子的结果与报道的体外数据相矛盾。在这些男性中,有10名用依托贝特降低甘油三酯治疗6周,增加了禁食和餐后C蛋白和纤溶酶原的产生,并且还稍微降低了fXII的激活。然而,它并不能逆转餐后PAP的增加或改变凝血酶原激活片段1 + 2的减少。我们的发现表明,餐后脂蛋白可在抗血栓形成和纤溶酶的方向上积极改变止血标志物。另外,用依托贝特降低甘油三酸酯治疗只能在抗血栓形成和纤溶蛋白的方向上稍微改善禁食和餐后止血的标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号